Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA||- / 1||- / OT|
Administered by: Unknown Purchased by: ??
Symptoms: Influenza, Pneumonia, SARS-CoV-2 test
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: VIMOVO; ACEMIN [ACECLOFENAC]; SEDACORON; ELIQUIS; MEXALEN; CONCOR; CAL-D-VITA; OLEOVIT D3
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation (Heart failure and atrial fibrillation(but condition was stable according to internist)); Cardiac insufficiency (Heart failure and atrial fibrillation(but condition was stable according to internist)); COVID-19 PCR test negative
Diagnostic Lab Data: Test Name: PCR test; Test Result: Negative ; Result Unstructured Data: Negative
CDC 'Split Type': ATMODERNATX, INC.MOD20211
Write-up: Bilateral bacterial pneumonia; Flu symptoms; This regulatory authority case was reported by a consumer and describes the occurrence of PNEUMONIA (Bilateral bacterial pneumonia) in a 73-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Cardiac insufficiency (Heart failure and atrial fibrillation(but condition was stable according to internist)), Atrial fibrillation (Heart failure and atrial fibrillation(but condition was stable according to internist)) and COVID-19 PCR test negative. Concomitant products included ACECLOFENAC (ACEMIN [ACECLOFENAC]) for COVID-19 vaccination, ESOMEPRAZOLE MAGNESIUM, NAPROXEN (VIMOVO), AMIODARONE HYDROCHLORIDE (SEDACORON), APIXABAN (ELIQUIS), PARACETAMOL (MEXALEN), BISOPROLOL FUMARATE (CONCOR), CALCIUM CARBONATE, COLECALCIFEROL (CAL-D-VITA) and COLECALCIFEROL (OLEOVIT D3) for an unknown indication. On 10-Apr-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PNEUMONIA (Bilateral bacterial pneumonia) (seriousness criterion death) and INFLUENZA (Flu symptoms). On 26-Apr-2021, INFLUENZA (Flu symptoms) outcome was unknown. The patient died on 26-Apr-2021. The reported cause of death was Pneumonia and Decompensation cardiac. An autopsy was not performed. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative. Treatment medications were not reported. Very limited information regarding this patient''s death has been provided at this time. Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Translation received on 02-JUN-2021 and added lab data.; Sender''s Comments: Very limited information regarding this patient''s death has been provided at this time.; Reported Cause(s) of Death: Pneumonia; Decompensation cardiac
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166